Getting genomics into healthcare: look to the UK
During Cancer Crosslinks 2019 one thing was crystal clear: there is a need to include broader genomic testing into treatments for cancer patients in Norway.
This author has yet to write their bio.Meanwhile lets just say that we are proud Wenche Gerhardsen contributed a whooping 52 entries.
During Cancer Crosslinks 2019 one thing was crystal clear: there is a need to include broader genomic testing into treatments for cancer patients in Norway.
Why is a Nordic mentor network a good idea for Norwegian start ups working in cancer?
Today, Thursday 17 January, we broadcast LIVE from our conference Cancer Crosslinks at Oslo Cancer Cluster Innovation Park.
New research could help to streamline the development of exciting new immunotherapy approaches for treating cancer.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.